SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. P. Casula, P. S. Bisiacchi, M. Corrias, S. Schiff, C. Merkel, P. Amodio, S. Montagnese, Acute hyperammonaemia induces a sustained decrease in vigilance, which is modulated by caffeine, Metabolic Brain Disease, 2014,

    CrossRef

  2. 2
    Cintia Rabelo e Paiva Caria, Caroline Candida de Oliveira, Érica Ferreira Martins Gotardo, Veronica Trícoli de Souza, Thalita Rocha, Juliana Alves Macedo, Patricia de Oliveira Carvalho, Marcelo Lima Ribeiro, Alessandra Gambero, Caffeinated and decaffeinated instant coffee consumption partially reverses high-fat diet-induced metabolic alterations in mice, Food Research International, 2014, 61, 120

    CrossRef

  3. 3
    Min Cheng, Zunsong Hu, Xiangfeng Lu, Jianfeng Huang, Dongfeng Gu, Caffeine Intake and Atrial Fibrillation Incidence: Dose Response Meta-analysis of Prospective Cohort Studies, Canadian Journal of Cardiology, 2014, 30, 4, 448

    CrossRef

  4. 4
    Rohit A. Sinha, Benjamin L. Farah, Brijesh K. Singh, Monowarul M. Siddique, Ying Li, Yajun Wu, Olga R. Ilkayeva, Jessica Gooding, Jianhong Ching, Jin Zhou, Laura Martinez, Sherwin Xie, Boon-Huat Bay, Scott A. Summers, Christopher B. Newgard, Paul M. Yen, Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice, Hepatology, 2014, 59, 4
  5. 5
    Shaohua Chen, Narci C Teoh, Shiv Chitturi, Geoffrey C Farrell, Coffee and non-alcoholic fatty liver disease: Brewing evidence for hepatoprotection?, Journal of Gastroenterology and Hepatology, 2014, 29, 3
  6. 6
    Kiran Bambha, Laura A. Wilson, Aynur Unalp, Rohit Loomba, Brent A. Neuschwander-Tetri, Elizabeth M. Brunt, Nathan M. Bass, Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis, Liver International, 2014, 34, 8
  7. 7
    Federico Salomone, Giovanni Li Volti, Paola Vitaglione, Filomena Morisco, Vincenzo Fogliano, Agata Zappalà, Angelo Palmigiano, Domenico Garozzo, Nicola Caporaso, Giuseppe D’Argenio, Fabio Galvano, Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease, Translational Research, 2014, 163, 6, 593

    CrossRef

  8. 8
    Silmara Rodrigues Machado, Edison Roberto Parise, Luciana de Carvalho, Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations, The Brazilian Journal of Infectious Diseases, 2014, 18, 2, 170

    CrossRef

  9. 9
    George Boon-Bee Goh, Wan-Cheng Chow, Renwei Wang, Jian-Min Yuan, Woon-Puay Koh, Coffee, alcohol and other beverages in relation to cirrhosis mortality: The Singapore Chinese Health Study, Hepatology, 2014, 60, 2
  10. 10
    Wen-Xing Ding, Drinking coffee burns hepatic fat by inducing lipophagy coupled with mitochondrial β-oxidation, Hepatology, 2014, 59, 4
  11. 11
    Ina Marie Andersen, Guro Tengesdal, Benedicte Alexandra Lie, Kirsten Muri Boberg, Tom Hemming Karlsen, Johannes Roksund Hov, Effects of Coffee Consumption, Smoking, and Hormones on Risk for Primary Sclerosing Cholangitis, Clinical Gastroenterology and Hepatology, 2014, 12, 6, 1019

    CrossRef

  12. 12
    Jonathan A. Dranoff, Jordan J. Feld, Élise G. Lavoie, Michel Fausther, How does coffee prevent liver fibrosis? biological plausibility for recent epidemiological observations, Hepatology, 2014, 60, 2
  13. 13
    Sammy Saab, Divya Mallam, Gerald A. Cox, Myron J. Tong, Impact of coffee on liver diseases: a systematic review, Liver International, 2014, 34, 4
  14. 14
    E. Jaeckel, R. Taubert, M.P. Manns, Leber und Diabetes, Der Diabetologe, 2014, 10, 5, 405

    CrossRef

  15. 15
    A Floegel, A Wientzek, U Bachlechner, S Jacobs, D Drogan, C Prehn, J Adamski, J Krumsiek, M B Schulze, T Pischon, H Boeing, Linking diet, physical activity, cardiorespiratory fitness and obesity to serum metabolite networks: findings from a population-based study, International Journal of Obesity, 2014,

    CrossRef

  16. 16
    Toshie Otake, Jin Fukumoto, Masao Abe, Shigeki Takemura, Pham Ngoc Mihn, Tetsuya Mizoue, Chikako Kiyohara, Linking lifestyle factors and insulin resistance, based on fasting plasma insulin and HOMA-IR in middle-aged Japanese men: A cross-sectional study, Scandinavian Journal of Clinical & Laboratory Investigation, 2014, 1

    CrossRef

  17. 17
    Mariana Verdelho Machado, Helena Cortez-Pinto, Management of fatty liver disease with the metabolic syndrome, Expert Review of Gastroenterology & Hepatology, 2014, 8, 5, 487

    CrossRef

  18. 18
    Fabio Marra, Angela Provenzano, Elisa Vivoli, Mechanisms of Fibrosis in Steatohepatitis, Current Hepatology Reports, 2014, 13, 2, 142

    CrossRef

  19. 19
    Xuan Zou, Chunhong Yan, Yujie Shi, Ke Cao, Jie Xu, Xun Wang, Cong Chen, Cheng Luo, Yuan Li, Jing Gao, Wentao Pang, Jialong Zhao, Fei Zhao, Hao Li, Adi Zheng, Wenyan Sun, Jiangang Long, Ignatius Man-Yau Szeto, Youyou Zhao, Zhizhong Dong, Peifang Zhang, Junkuan Wang, Wuyuan Lu, Yong Zhang, Jiankang Liu, Zhihui Feng, Mitochondrial Dysfunction in Obesity-Associated Nonalcoholic Fatty Liver Disease: The Protective Effects of Pomegranate with Its Active Component Punicalagin, Antioxidants & Redox Signaling, 2014, 140218122015002

    CrossRef

  20. 20
    J. K. Dyson, Q. M. Anstee, S. McPherson, Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging, Frontline Gastroenterology, 2014, 5, 3, 211

    CrossRef

  21. 21
    Sean W.P. Koppe, Obesity and the liver: nonalcoholic fatty liver disease, Translational Research, 2014,

    CrossRef

  22. 22
    Franziska Ferk, Wolfgang W. Huber, Bettina Grasl-Kraupp, Karl Speer, Sandra Buchmann, Rene Bohacek, Miroslav Mišík, Leopold Edelbauer, Siegfried Knasmüller, Protective effects of coffee against induction of DNA damage and pre-neoplastic foci by aflatoxin B1, Molecular Nutrition & Food Research, 2014, 58, 2
  23. 23
    Richele L. Corrado, Dawn M. Torres, Stephen A. Harrison, Review of Treatment Options for Nonalcoholic Fatty Liver Disease, Medical Clinics of North America, 2014, 98, 1, 55

    CrossRef

  24. 24
    Min-Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Yoon Jun Kim, Jung-Hwan Yoon, Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance, Liver International, 2014, 34, 8
  25. You have free access to this content25
    Z. M. Younossi, M. J. Reyes, A. Mishra, R. Mehta, L. Henry, Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets, Alimentary Pharmacology & Therapeutics, 2014, 39, 1
  26. 26
    Ioanna-Panagiota Kalafati, Dimitra Borsa, George V. Z. Dedoussis, The Genetics of Nonalcoholic Fatty Liver Disease: Role of Diet as a Modifying Factor, Current Nutrition Reports, 2014, 3, 3, 223

    CrossRef

  27. 27
    Pankaj Puri, Autophagy and Liver Disease, Journal of Clinical and Experimental Hepatology, 2013, 3, 3, 262

    CrossRef

  28. 28
    Bashar M. Attar, David H. Van Thiel, Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease, The Scientific World Journal, 2013, 2013, 1

    CrossRef

  29. 29
    Romilda Cardin, Marika Piciocchi, Diego Martines, Laura Scribano, Marino Petracco, Fabio Farinati, Effects of coffee consumption in chronic hepatitis C: A randomized controlled trial, Digestive and Liver Disease, 2013, 45, 6, 499

    CrossRef

  30. 30
    Thomas Karlas, Johannes Wiegand, Thomas Berg, Gastrointestinal complications of obesity: Non-alcoholic fatty liver disease (NAFLD) and its sequelae, Best Practice & Research Clinical Endocrinology & Metabolism, 2013, 27, 2, 195

    CrossRef

  31. 31
    Tatsuya Nakayama, Kazunori Oishi, Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses, FEMS Microbiology Letters, 2013, 343, 2
  32. 32
    Dawn M. Torres, Stephen A. Harrison, Is It Time to Write a Prescription for Coffee? Coffee and Liver Disease, Gastroenterology, 2013, 144, 4, 670

    CrossRef

  33. 33
    A. Yesil, Y. Yilmaz, Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2013, 38, 9
  34. You have free access to this content34
    Jian-Gao Fan, Hai-Xia Cao, Role of diet and nutritional management in non-alcoholic fatty liver disease, Journal of Gastroenterology and Hepatology, 2013, 28,
  35. You have free access to this content35
    Angelo H. Paredes, Dawn M. Torres, Stephen A. Harrison, Tratamiento de la enfermedad por hígado graso no alcohólico: Papel de las modificaciones dietéticas y el ejercicio, Clinical Liver Disease, 2013, 2, S4
  36. 36
    Ajay K. Duseja, Coffee and Liver – Long Way To Go, Journal of Clinical and Experimental Hepatology, 2012, 2, 3, 291

    CrossRef

  37. 37
    Dawn M. Torres, Christopher D. Williams, Stephen A. Harrison, Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology and Hepatology, 2012, 10, 8, 837

    CrossRef

  38. 38
    Sofia Carvalhana, Mariana Verdelho Machado, Helena Cortez-Pinto, Improving dietary patterns in patients with nonalcoholic fatty liver disease, Current Opinion in Clinical Nutrition and Metabolic Care, 2012, 15, 5, 468

    CrossRef

  39. 39
    Anthony Fardet, Jean-François Martin, Djilali Touazi, France Caillavet, Jean-Michel Chardigny, Lipotropes from plant-based foods supplied by a standard French diet vs. food guide pyramid recommendations: Grain products are the best sources at lower cost, Journal of Food Composition and Analysis, 2012, 28, 2, 135

    CrossRef

  40. You have full text access to this OnlineOpen article40
    Emmanuel A. Tsochatzis, Jaime Bosch, Andrew K. Burroughs, New therapeutic paradigm for patients with cirrhosis, Hepatology, 2012, 56, 5
  41. 41
    Angelo H. Paredes, Dawn M. Torres, Stephen A. Harrison, Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2012, 16, 2, 397

    CrossRef

  42. 42
    Selected Literature Watch, Journal of Caffeine Research, 2012, 2, 1, 48

    CrossRef

  43. You have free access to this content43
    Angelo H. Paredes, Dawn M. Torres, Stephen A. Harrison, Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exercise, Clinical Liver Disease, 2012, 1, 4